Christoforos Meliadis

Dr. Christoforos Meliadis

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2024 in IEEE Open Journal of Engineering in Medicine and Biology
Verified
Journal Article
Open access
CMChristoforos Meliadis
Christoforos Meliadis
EFEmily Feng
Emily Feng
EJEzekiel Johnson
Ezekiel Johnson
WZWendy Zhu
Wendy Zhu
PGParamesh Gopi
Paramesh Gopi
BLBryant Y. Lin
Bryant Y. Lin
Goal: This study aims to introduce a novel method for estimating maxillary sinus volume using smartphone technology, providing an accessible alternative to traditional imaging techniques. Methods: We recruited 40 participants to conduct a comparative analysis between Computed Tomography (CT) and face scans obtained using an Apple iPhone. Utilizing Apple's ARKit for 3D facial mesh modeling, we estimated sinus dimensions based on established craniofacial landmarks and calculated the volume through a geometric approximation of the maxillary sinus. Results: We demonstrated a high degree of agreement between CT and face scans, with Mean Absolute Percentage Errors (MAPE) of 8.006 ± 8.839% (Width), 6.725 ± 4.595% (Height), 9.952 ± 6.733% (Depth), and 10.429 ± 7.409% (Volume). These results suggest the feasibility of this non-invasive approach for clinical use. Conclusions: This method aligns with the growing focus on telemedicine, presenting significant reductions in healthcare costs and radiation exposure from CT scans. It marks a substantial advancement in otolaryngology and maxillofacial surgery, showcasing the integration of smartphone technology in medical diagnostics and opening avenues for innovative, patient-friendly, and cost-effective healthcare solutions.

27 December 2025 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
CYCristal S. Yee
Cristal S. Yee
MDMarianne Demirdji
Marianne Demirdji
KBKarsyn N. Bailey
Karsyn N. Bailey
ALAlena D. Larios
Alena D. Larios
CMChristoforos Meliadis
Christoforos Meliadis
TATamara Alliston
Tamara Alliston
Cartilage in the knee and temporomandibular joint (TMJ) rely on subchondral bone for joint homeostasis, whereby osteoarthritis (OA) causes degeneration. In the knee, suppression of osteocytic perilacunocanalicular remodeling drives cartilage degeneration in a destabilization of the medial meniscus model of OA. Given the structural and functional differences between knee and TMJ osteochondral tissues, whether osteocytes also play a causal role in TMJOA remains to be determined. We hypothesize that subchondral bone osteocytes are required for TMJ homeostasis. We evaluated the role of osteocytic MMP13 in the TMJ using 16-week-old mixed FVB and C57BL/6 male mice with osteocyte-intrinsic loss of MMP13 (DMP1-cre+/-;MMP13fl/fl). DMP1-cre+/-;MMP13fl/fl or Cre-negative (Control) mice received intraarticular saline or monosodium iodoacetate (MIA) to induce injury. Effects of MMP13-dependent osteocyte dysfunction on TMJ or knee OA were determined by histology and microCT. Unlike baseline differences in knees of DMP1-cre+/-;MMP13fl/fl and Controls, osteocytic MMP13-deficiency had no discernible effects on TMJ cartilage and subchondral bone in the absence of injury. Relative to saline Control, MIA Control mice had cartilage degeneration, with higher modified TMJ Mankin scores (p<0.001; 95%CI [-7.7 to -1.9]). MIA-injured Controls also had increased osteocyte lacunar number (p=0.03; 95% CI [-394.2 to -14.8]) and a genotype and treatment interaction effect on TRAP stain (p=0.0213;36.04% of total variation). Contrary to our hypothesis, TMJs of MIA-injured DMP1-cre+/-;MMP13fl/fl mice were protected from cartilage degeneration or subchondral bone changes. Relative to Cre-negative Controls, DMP1-cre+/-;MMP13fl/fl knees showed resistance to injury-induced increase in subchondral bone plate thickness. Despite different roles for osteocytic MMP13 in TMJ and knee, osteocytic MMP13 deficiency protects both joints from injury-dependent effects on subchondral bone.

30 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Michail SpanosMichail Spanos
Michail Spanos
RDRaptis Dimitrios
Raptis Dimitrios
FCFRANCO JOAQUIN COSSETTINI
FRANCO JOAQUIN COSSETTINI
ABArmend Balidemaj
Armend Balidemaj
ARAshwin Ragupathi
Ashwin Ragupathi
DKDamianos G. Kokkinidis
Damianos G. Kokkinidis
Background/Objectives: Congestion drives most heart-failure (HF) hospitalizations, and several strategies now titrate therapy to a directly measured congestion signal rather than to symptoms; whether they differ by the signal measured has not been examined comparatively. Methods: We performed a systematic review and contrast-based network meta-analysis of randomized trials comparing imaging- or device-based congestion-triggered management with usual care. Thirteen chronic-phase trials formed a star network (no closed loops; rankings exploratory) of four strategies, pressure-guided (N1), lung ultrasound (N2), transthoracic lung impedance (N3), and cardiac-implantable-electronic-device (CIED) intrathoracic impedance (N5), with HF hospitalization as the primary outcome and six prespecified sensitivity analyses; four acute trials formed a gap map. Results: Only pressure-guided monitoring reduced HF hospitalization (0.72, 95% confidence interval 0.57–0.90), stable across sensitivities and matching external data. Lung ultrasound did not reduce hospitalization (0.72, 0.48–1.08) or mortality but reduced urgent visits (0.26, 0.13–0.50). The apparent CIED-impedance harm (1.12, 0.77–1.63) reflected an audible-alert trial and dissolved when early-terminated trials were excluded (0.87). Lung impedance gave the largest estimate (0.51, 0.31–0.83) but rested on one trial. No strategy tested in more than one trial reduced mortality. Conclusions: The congestion signal acted upon, and who receives the alert, track with the effect, although signal and workflow cannot be separated within trials; clinicians should match modality to the intended outcome, as these tools defer hospitalization, not death.